Development of n-Type Semiconductor Based on Cyclopentene- or Cyclohexene-Fused [C60]-Fullerene Derivatives
摘要:
Properties of cydopentene- or cyclohexene-fused [C-60]-fullerene derivatives as the acceptor in photovoltaic cells have been investigated by use of poly(3-hexylthiophene) (P3HT) as the model donor polymer. Several cyclopentene- or cyclohexene-fused [C-60]-fullerene derivatives show high power conversion efficiency (PCB). The highest PCE was obtained for 3',6'-dihydro-4'-phenoxycarbonyl-6'-methylbenzo[1,9][5,6] (C-60-I-h)fullerene (3.2%); this is superior to that of [C-60]-PCBM with the P3HT polymer under the same experimental conditions. PCE of the OPV devices with alkyl-substituted cydohexene-fused [C-60],fullerenes depended on the alkyl substituent on the cyclohexene ring; compounds with substituents of odd-number alkyl groups showed better PCE than those compounds possessing even-number alkyl groups.
CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY
申请人:Cerulean Pharma Inc.
公开号:US20130196906A1
公开(公告)日:2013-08-01
Provided are methods relating to the use of CDP-therapeutic agent conjugates for the treatment of a disease or disorder, e.g., autoimmune disease, inflammatory disease, central nervous system disorder, cardiovascular disease, or metabolic disorder. Also provided are CDP-therapeutic agent conjugates, particles comprising CDP-therapeutic agent conjugates, and compositions comprising CDP-therapeutic agent conjugates.
ALKALOID MONOMERS, LIQUID CRYSTAL COMPOSITIONS AND POLYMER NETWORKS DERIVED THEREFROM
申请人:Goldfinger Marc B.
公开号:US20110193019A1
公开(公告)日:2011-08-11
Disclosed is the chemical synthesis of chiral alkaloid monomers, liquid crystal compositions comprising the chiral alkaloid monomers, and polymerization of the liquid crystal compositions to provide polymer networks with useful cholesteric optical properties and stability.
[EN] LIGHT HARVESTING ARRAY<br/>[FR] RÉSEAU COLLECTEUR DE LUMIÈRE
申请人:FLUROSOL IND PTY LTD
公开号:WO2015024064A1
公开(公告)日:2015-02-26
The invention relates to a light harvesting array or dye comprising an acceptor linked to a donor, wherein at least one of the acceptor or the donor is an oligomeric unit comprising a first optionally substituted rylene linked via a linker group to a second optionally substituted rylene, the first optionally substituted rylene is linked to the acceptor or the donor and the second optionally substituted rylene is capable of energy transfer to at least one of the first optionally substituted rylene, the acceptor or the donor. The invention also relates to compounds which may be used as light harvesting arrays, methods for their manufacture, and devices and materials comprising the light harvesting array or dye, for example, chromophoric materials, light guides, photobioreactors, photoluminescent algae systems, photodetectors, photovoltaic devices and luminescent/fluorescent solar concentrators.
[EN] CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY<br/>[FR] POLYMÈRES À BASE DE CYCLODEXTRINE POUR UNE ADMINISTRATION THÉRAPEUTIQUE
申请人:CERULEAN PHARMA INC
公开号:WO2011063421A1
公开(公告)日:2011-05-26
Methods and compositions relating to CDP-taxane conjugates are described herein.
这里描述了与CDP-紫杉醇共轭物相关的方法和组合物。
[EN] METHODS OF TREATING A SUBJECT AND RELATED PARTICLES, POLYMERS AND COMPOSITIONS<br/>[FR] MÉTHODES DE TRAITEMENT D'UN SUJET ET PARTICULES, POLYMÈRES ET COMPOSITIONS À CET EFFET
申请人:FETZER OLIVER S
公开号:WO2012044832A1
公开(公告)日:2012-04-05
Described herein are methods for treating a subject with combinations of polymer-agent particles and cyclodextrin polymer agent conjugates. The methods herein may be used to treat subjects identified with cancer, cardiovascular disorders, autoimmune disorders, or inflammatory disorders. Also described herein are compositions, dosage forms, and kits comprising polymer-agent particles and cyclodextrin polymer agent conjugates.